Category:
Active Pharmaceutical Ingredients
CAS NO:
606143-89-9
Standard:
In-house Standards,
Oncology Melanoma
Binimetinib (MEK162) is a potent, selective oral inhibitor of MEK1/2. Its core synthesis involves advanced organic coupling and chiral resolution. Formula: C24H24N8O2; CAS: 933570-89-5.
Strictly regulated as an investigational new drug; requires controlled storage at -20°C under inert atmosphere to prevent hydrolysis. Clinical use limited to specific genetic profiles with severe hepatotoxicity monitoring.